Comparison of PPARδ and PPARγ in inhibiting the pro-inflammatory effects of C-reactive protein in endothelial cells.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Cardiology

• Publication date

  2010-09-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2009.03.100PMID 19395102
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation in Atherosclerosis

  2012cited by this paper
• C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo.

  2009cited by this paper
• Ethical authorship and publishing.

  2009cited by this paper
• PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis

  2008cited by this paper
• Apolipoprotein CIII–Induced THP-1 Cell Adhesion to Endothelial Cells Involves Pertussis Toxin–Sensitive G Protein– and Protein Kinase C&agr;–Mediated Nuclear Factor-&kgr;B Activation

  2007cited by this paper
• C-reactive protein activates the nuclear factor-κB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells

  2006cited by this paper
• PPARδ: a dagger in the heart of the metabolic syndrome

  2006cited by this paper
• CRP promotes monocyte-endothelial cell adhesion via Fcgamma receptors in human aortic endothelial cells under static and shear flow conditions.

  2006cited by this paper
• PPAR delta: a dagger in the heart of the metabolic syndrome.

  2006cited by this paper
• C-reactive protein activates the nuclear factor-kappaB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells.

  2006cited by this paper
• C-Reactive Protein Augments Interleukin-8 Secretion in Human Peripheral Blood Monocytes

  2005cited by this paper
• Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis.

  2004cited by this paper
• Effect of C-reactive protein on chemokine expression in human aortic endothelial cells.

  2004cited by this paper
• Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB-C/EBP-β complex formation

  2003cited by this paper
• Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ

  2003cited by this paper
• Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications

  2003cited by this paper
• Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation.

  2003cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

  2002cited by this paper
• Constitutive Activation of Peroxisome Proliferator-activated Receptor-γ Suppresses Pro-inflammatory Adhesion Molecules in Human Vascular Endothelial Cells*

  2002cited by this paper
• Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.

  2002cited by this paper
• Inflammation in atherosclerosis

  2002cited by this paper
• Stabilization of atherosclerotic plaques: New mechanisms and clinical targets

  2002cited by this paper
• PPAR expression and function during vertebrate development.

  2002cited by this paper
• The Peroxisome Proliferator-activated Receptor δ Promotes Lipid Accumulation in Human Macrophages*

  2001cited by this paper
• Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.

  2001cited by this paper
• A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport

  2001cited by this paper
• Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer

  2001cited by this paper
• Modulation of C-Reactive Protein-Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs

  2001cited by this paper
• The Transcription Factor NF-κB and the Regulation of Vascular Cell Function

  2000cited by this paper
• Molecular recognition of fatty acids by peroxisome proliferator-activated receptors.

  2000cited by this paper
• The transcription factor NF-kappa B and the regulation of vascular cell function.

  2000cited by this paper
• The Major Receptor for C-Reactive Protein on Leukocytes Is Fcγ Receptor II

  1999cited by this paper
• The Major Receptor for C-Reactive Protein on Leukocytes Is Fcγ Receptor II

  1999cited by this paper
• Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library.

  1997cited by this paper
• Wide Web at:

  year unknowncited by this paper

• Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders

  2025cites this paper
• Distinct Roles of PPARs in Atherosclerosis.

  2025cites this paper
• PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets

  2024cites this paper
• PPAR-δ: A key nuclear receptor in vascular function and remodeling.

  2022cites this paper
• Association between serum vitamin D, hs-CRP, and prooxidant-antioxidant balance with anthropometric and biochemical parameters in patients with diabetic foot ulcers

  2021cites this paper
• PPARβ/δ ligands regulate the expression of immune response mediators in the porcine endometrium - An in vitro study.

  2019cites this paper
• PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma.

  2018cites this paper
• Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells

  2017cites this paper
• PPARβ/δ: A master regulator of mesenchymal stem cell functions.

  2017cites this paper
• The Association of Peroxisome Proliferator-Activated Receptor δ and Additional Gene-Gene Interaction with C-Reactive Protein in Chinese Population

  2016cites this paper
• Effect of obesity on the association between common variations in the PPAR gene and C-reactive protein level in Chinese Han population

  2015cites this paper
• Activation of PPARδ: from computer modelling to biological effects

  2015cites this paper
• The role of PPARδ signaling in the cardiovascular system.

  2014cites this paper
• Physiological functions of peroxisome proliferator-activated receptor β.

  2014cites this paper
• L-165,041, troglitazone and their combination treatment to attenuate high glucose-induced receptor for advanced glycation end products (RAGE) expression.

  2013cites this paper
• Peroxisome proliferator-activated receptor delta and cardiovascular disease.

  2013cites this paper
• PPARδ Agonist GW501516 Inhibits PDGF-Stimulated Pulmonary Arterial Smooth Muscle Cell Function Related to Pathological Vascular Remodeling

  2013cites this paper
• Nuclear Control of the Inflammatory Response in Mammals by Peroxisome Proliferator-Activated Receptors

  2013cites this paper
• Pleiotropic effects of peroxisome proliferator-activated receptor γ and δ in vascular diseases.

  2013cites this paper
• Vascular effects of glycoprotein130 ligands--part II: biomarkers and therapeutic targets.

  2012cites this paper
• Peroxisome proliferator-activated receptor δ downregulates the expression of the receptor for advanced glycation end products and pro-inflammatory cytokines in the kidney of streptozotocin-induced diabetic mice.

  2011cites this paper
• Peroxisome Proliferator-activated Receptor δ Activators Induce IL-8 Expression in Nonstimulated Endothelial Cells in a Transcriptional and Posttranscriptional Manner*

  2010cites this paper
• Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.

  2010cites this paper
• Metabolic and nonmetabolic regulatory functions of peroxisome proliferator-activated receptor β

  2010cites this paper